BamSEC and AlphaSense Join Forces
Learn More

OptimizeRx Corporation

NASDAQ: OPRX    
Share price (11/27/24): $5.33    
Market cap (11/27/24): $98.2 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 1 page Amendment No.1 to the OptimizeRx Corporation 2021 Equity Incentive Plan
12/34/56
EX-10.28
from 10-K 20 pages OptimizeRx Corporation Executive Severance Plan* Plan Document/Summary Plan Description
12/34/56
EX-10.27
from 10-K 8 pages Amended and Restated Employment Agreement by and Between the Company and Stephen Silvestro Dated April 12, 2024
12/34/56
EX-10.26
from 10-K 7 pages Fifth Addendum to the Employment Agreement With William J. Febbo Dated April 12, 2024
12/34/56
EX-10.1
from 8-K 9 pages Amendment No. 1 to Financing Agreement
12/34/56
EX-10.1
from 8-K 6 pages Common Stock Purchase Agreement
12/34/56
EX-10.4
from 8-K 5 pages Fee Letter
12/34/56
EX-10.3
from 8-K 133 pages Financing Agreement Dated as of October 11, 2023 by and Among OptimizeRx Corporation, as the Lead Borrower, the Lenders From Time to Time Party Hereto, as Lenders, and Blue Torch Finance, LLC, as Administrative Agent and Collateral Agent
12/34/56
EX-10.2
from 8-K 9 pages Joinder and Support Agreement to Agreement and Plan of Merger
12/34/56
EX-10.1
from 8-K 77 pages Agreement and Plan of Merger by and Among OptimizeRx Corporation, Healthy Offers, Inc., the Securityholders of Healthy Offers, Inc., and Michael Weintraub, as Securityholder Representative Dated as of October 11, 2023
12/34/56
EX-10.19
from 10-K 2 pages March 8, 2023 Mr. William Febbo Re: Fourth Addendum to the Offer Letter, Dated February 25, 2019, as Amended, by and Between William Febbo and OptimizeRx Corporation Change in Control Termination
12/34/56
EX-10.18
from 10-K 19 pages OptimizeRx Corporation Executive Severance Plan Plan Document/Summary Plan Description
12/34/56
EX-10.3
from 8-K 1 page Amendment to Employment Agreement
12/34/56
EX-10.2
from 8-K 1 page Second Amendment to Employment Agreement
12/34/56
EX-10.1
from 8-K 5 pages OptimizeRx Corporation 2022 Cash Bonus Plan
12/34/56
EX-10.1
from 8-K 2 pages Letter Agreement by and Between the Company and Miriam Paramore
12/34/56
EX-10.1
from 8-K 2 pages September 22, 2021 William Febbo Re: Third Addendum to the Offer Letter, Dated February 25, 2019, as Amended, by and Between William Febbo and OptimizeRx Corporation
12/34/56
EX-10.1
from 8-K 3 pages Offer Letter by and Between the Company and Edward Stelmakh
12/34/56
EX-10.5
from 8-K 4 pages OptimizeRx Corporation 2021 Equity Incentive Plan Notice of Restricted Stock Unit Grant
12/34/56
EX-10.4
from 8-K 3 pages OptimizeRx Corporation 2021 Equity Incentive Plan Notice of Restricted Stock Unit Grant
12/34/56